Safety Alerts & Recalls

Search all Safety Alerts & Recalls

Latest Alerts

Potential increased risk of heart attack
The FDA has notified healthcare professionals today that they are investigating a potential link between { drug_name } and an increased risk of heart attack. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm070263.htm
Learn More

Potential increased risk of heart attack
The FDA has notified healthcare professionals today that they are investigating a potential link between { drug_name } and an increased risk of heart attack. For more information, please visit: http://www.fda.gov/Drugs/DrugSafety/PostmarketDrugSafetyInformationforPatientsandProviders/DrugSafetyInformationforHeathcareProfessionals/ucm070263.htm
Learn More

Receive Safety Alerts & Recalls by email or text message.

Register

Date Published Title Drug Source
2008-03-27 Potential increased risk of heart attack Abacavir FDA
2008-03-27 Potential increased risk of heart attack Didanosine FDA
2008-03-27 Recall of selected 300mg tablets Bupropion FDA
2008-03-20 Recall of patches in the United States and Europe Rotigotine Manufacturer
2008-03-18 Potential increased risk of stroke identified Tiotropium FDA
2008-03-11 Public health advisory on the proper use of Tussionex Tussionex Pennkinetic FDA
2008-03-11 Public health advisory on the proper use of Tussionex FDA
2008-02-27 Risk of Clinically Significant Liver Injury Natalizumab FDA
2008-02-13 Recall of fentanyl patches Fentanyl Manufacturer
2008-02-08 Early communication regarding FDA safety review Onabotulinumtoxina FDA
2008-02-08 Early communication regarding FDA safety review Rimabotulinumtoxinb FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Carbamazepine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Felbamate FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Gabapentin FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Lamotrigine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Levetiracetam FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Oxcarbazepine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Pregabalin FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Tiagabine FDA
2008-01-31 Increased risk of suicidal thoughts and behaviour Topiramate FDA
Back to Consumer Med Safety